“Real-World Experience of Upadacitinib Dosing Reduction in Patients With Moderate Atopic Dermatitis: A Case Series Study in Taiwan”, Dermatol Pract Concept, vol. 14, no. 3, p. e2024186, Jul. 2024, doi: 10.5826/dpc.1403a186.